Tag: younger patients

Innovation, Research

Ibrutinib plus standard chemotherapy effective in younger patients with diffuse large B-cell lymphoma

November 5, 2021

Via: The Medical News

Younger patients with specific genetic subtypes of non-GCB DLBCL, called MCD and N1, had an exceptional response to the treatment combination. New evidence suggests that adding the targeted therapy ibrutinib (Imbruvica) to a standard chemotherapy regimen can improve how long […]